Yi Lin
Impact in
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Cancer-related molecular mechanisms research 3
- Oncology 7
- CAR-T cell therapy research 2
- Co-authors
- Xuejiang Gu (3 shared papers)Yu‐Chun Lin (2 shared papers)Zhong‐Ning Lin (2 shared papers)Chengyong He (2 shared papers)Lijuan Yang (2 shared papers)Xiao Liang (1 shared paper)Liyin Zhang (1 shared paper)Yanghong Ni (1 shared paper)
- Journals
- Journal of Cellular and Molecular Medicine (2 papers)Frontiers in Plant Science (2 papers)iScience (2 papers)Adipocyte (1 paper)Cancer Science (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yi Lin
43 papers receiving 683 citations
Peers
Comparison fields: 5 of 99
- Pharmacology 55
- Cancer Research 67
- Molecular Biology 325
- Immunology 77
- Oncology 91
Countries citing papers authored by Yi Lin
This map shows the geographic impact of Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Lin more than expected).
Fields of papers citing papers by Yi Lin
This network shows the impact of papers produced by Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Lin. The network helps show where Yi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 90 | |
| 2 | 2022 | 79 | |
| 3 | 2018 | 52 | |
| 4 | 2019 | 46 | |
| 5 | 2013 | 46 | |
| 6 | 2020 | 41 | |
| 7 | 2019 | 33 | |
| 8 | 2023 | 33 | |
| 9 | 2024 | 30 | |
| 10 | 2019 | 22 | |
| 11 | 2024 | 21 | |
| 12 | 2020 | 21 | |
| 13 | 2022 | 16 | |
| 14 | 2021 | 16 | |
| 15 | 2022 | 14 | |
| 16 | 2014 | 14 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 11 | |
| 19 | 2023 | 10 | |
| 20 | 2023 | 9 |
About Yi Lin
Yi Lin is a scholar working on Cancer Research, Oncology, Molecular Biology, Physiology and Immunology, having authored 47 papers that have together received 693 indexed citations. Recurring topics across this work include Lipid metabolism and disorders (3 papers), Immune cells in cancer (3 papers), Meat and Animal Product Quality (3 papers), Biochemical effects in animals (3 papers), Cancer-related molecular mechanisms research (3 papers), Adipose Tissue and Metabolism (3 papers), Ginseng Biological Effects and Applications (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Pharmacology (55 citations), Cancer Research (67 citations), Molecular Biology (325 citations), Immunology (77 citations) and Oncology (91 citations). Yi Lin has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xuejiang Gu, Yu‐Chun Lin, Zhong‐Ning Lin, Chengyong He, Lijuan Yang, Xiao Liang, Liyin Zhang, Yanghong Ni, Yuanyuan Chen and Weihua Wang. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Frontiers in Plant Science, iScience, Adipocyte and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.